Related Experiment Video
Updated: Jan 5, 2026

Author Spotlight: Integrating High-Resolution Intravital Imaging and MRI to Enhance Stereotactic Body Radiation Therapy Planning
Published on: April 12, 2024
Microvascular invasion in hepatocellular carcinoma: is it predictable with quantitative computed tomography
Daniel Lahan-Martins1, Simone Reges Perales1, Stephanie Kilaris Gallani2
1Hospital de Clínicas da Universidade Estadual de Campinas (HC-Unicamp), Campinas, SP, Brazil.
Quantitative computed tomography (CT) measurements do not predict microvascular invasion (MVI) in hepatocellular carcinoma (HCC). Preoperative CT scans did not show a correlation with MVI, suggesting it is not a reliable predictor.
Area of Science:
- Hepatobiliary imaging
- Radiology
- Oncology
Background:
- Hepatocellular carcinoma (HCC) is a primary liver cancer.
- Microvascular invasion (MVI) is a key prognostic factor in HCC.
- Accurate preoperative prediction of MVI is crucial for treatment planning.
Purpose of the Study:
- To evaluate the predictive value of quantitative computed tomography (CT) parameters for microvascular invasion (MVI) in hepatocellular carcinoma (HCC).
Main Methods:
- Retrospective analysis of 200 HCC cases from 125 patients.
- Quantitative CT measurements of lesions and liver parenchyma across different phases (unenhanced, arterial, portal venous, equilibrium).
- Logistic regression analysis to assess CT parameters as predictors of MVI compared to histopathology.
Main Results:
- 38.5% of HCCs exhibited MVI on histopathological analysis.
- No significant statistical difference in percentage attenuation ratios or relative washout ratios between HCCs with and without MVI.
- Quantitative dynamic CT parameters did not correlate with MVI status.
Conclusions:
- Preoperative quantitative dynamic CT parameters are not reliable predictors of MVI in HCC.
- Further research may be needed to identify reliable imaging biomarkers for MVI prediction in HCC.
More Related Videos
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024